Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights-论文-万方医学网

Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights

导出原文传递

翻译打印收藏纠错

作者： Shibata, Tatsuhiro ; Nohara, Shoichiro ; Morikawa, Nagisa ; Shibao, Kodai ; Ito, Shinichiro ; Shibata, Ryo ; Toh, Uhi ; Nagafuji, Koji ; Fukami, Kei ; Fukumoto, Yoshihiro

关键词 Cardio-oncology Adverse cardiovascular event Haematologic malignancies Breast cancer Anthracyclines Human epidermal growth factor receptor 2 (HER2)-targeted therapies CARDIO-ONCOLOGY EUROPEAN ASSOCIATION AMERICAN SOCIETY DISEASE ECHOCARDIOGRAPHY RECOMMENDATIONS CARDIOTOXICITY CARFILZOMIB THERAPIES UPDATE

发布时间 2024-04-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights

相似文献

相关期刊

检索历史清除